ProShares UltraShort Health Care
2 hedge funds and large institutions have $37.1K invested in ProShares UltraShort Health Care in 2024 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.
28% more call options, than puts
Call options by funds: $18.6M | Put options by funds: $14.6M
12.14% less ownership
Funds ownership: 14.35% → 2.21% (-12%)
33% less funds holding
Funds holding: 3 → 2 (-1)
87% less capital invested
Capital invested by funds: $293K → $37.1K (-$256K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IMC Chicago
Chicago,
Illinois
|
-$267K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$8.79K |
RXD Hedge Fund Activity: Q2 2024 in Review
2 of the 6,900 institutional investors tracked by Wall St. Rank reported a position in ProShares UltraShort Health Care (RXD) for Q2 2024, worth a combined $37.1K — down 87% from $293K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of RXD and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest seller was IMC Chicago, exiting entirely with an estimated $267K sold.
- 2 institutional investors held ProShares UltraShort Health Care (RXD) as of Q2 2024, down from 3 in Q1 2024.
- Funds reported $37.1K of ProShares UltraShort Health Care stock for Q2 2024, down 87% quarter-over-quarter.
- 0 funds opened new ProShares UltraShort Health Care positions in Q2 2024 and 1 closed out, a net change of -1 holder.
- The largest ProShares UltraShort Health Care seller in Q2 2024 was IMC Chicago, an estimated $267K sold.
Based on aggregated 13F filings for Q2 2024.